Abstract:Genome targeting of restriction enzymes and DNA methyltransferases has many important applications including genome and epigenome editing. 15-20 years ago, my group was involved in the development of approaches for programmable genome targeting, aiming to connect enzymes with an oligodeoxynucleotide (ODN), which could form a sequence-specific triple helix at the genomic target site. Importantly, the target site of such enzyme-ODN conjugate could be varied simply by altering the ODN sequence promising great applicative values. However, this approach was facing many problems including the preparation and purification of the enzyme-ODN conjugates, their efficient delivery into cells, slow kinetics of triple helix formation and the requirement of a poly-purine target site sequence. Hence, for several years genome and epigenome editing approaches mainly were based on Zinc fingers and TAL proteins as targeting devices. More recently, CRISPR/Cas systems were discovered, which use a bound RNA for genome targeting that forms an RNA/DNA duplex with one DNA strand of the target site. These systems combine all potential advantages of the once imagined enzyme-ODN conjugates and avoid all main disadvantageous. Consequently, the application of CRISPR/Cas in genome and epigenome editing has exploded in recent years. We can draw two important conclusions from this example of research history. First, evolution still is the better bioengineer than humans and, whenever tested in parallel, natural solutions outcompete engineered ones. Second, CRISPR/Cas system were discovered in pure, curiosity driven, basic research, highlighting that it is basic, bottom-up research paving the way for fundamental innovation.

Impact of Chromatin Organization and Epigenetics on CRISPR-Cas and TALEN Genome Editing

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Advances in CRISPR-Cas systems for epigenetics

Development and application of CRISPR/Cas9 technologies in genomic editing.

CRISPR Double Cutting Through the Labyrinthine Architecture of 3D Genomes

Genome-Editing Technologies: Principles and Applications.

Dissecting the mechanism of CRISPR–Cas technologies to design efficient biotechnologies

An overview and potential of CRISPR-Cas systems for genome editing

The advances in CRISPR technology and 3D genome

Cas9-Based Tools For Targeted Genome Editing And Transcriptional Control

From Bioengineering to CRISPR/Cas9 - A Personal Retrospective of 20 Years of Research in Programmable Genome Targeting

Genome-wide specificity of DNA binding, gene regulation, and chromatin remodeling by TALE- and CRISPR/Cas9-based transcriptional activators

Genome Editing Technology and Medical Applications.

CRISPR-Cas Systems: Overview, Innovations and Applications in Human Disease Research and Gene Therapy

The new frontier of genome engineering with CRISPR-Cas9

CRISPR/Cas9 for Genome Editing: Progress, Implications and Challenges.

Mechanism of CRISPER/Cas9-Mediated Genome Editing: Scope and Opportunities

Epigenome editing technologies for discovery and medicine

Research Advances on CRISPR-Cas Genome Editing Technology